TP53 and non-small cell lung carcinoma: In the 1093 patients from the LUAD and LUSC datasets, 50 patients with stage IA NSCLC who have mutation data available had undergone definite R0 surgical resection without prior cancer diagnosis occurence, and the clinicopathologic characteristics of the TP53 mutations are shown in Table 1.